Anadys Pharmaceuticals, Inc. Investor Lawsuit Against Takeover by Roche Announced by Shareholders Foundation
(firmenpresse) - SAN DIEGO, CA -- (Marketwire) -- 10/24/11 -- The Shareholders Foundation, Inc. announces that an investor filed a lawsuit in State Court for current investors in the Anadys Pharmaceuticals, Inc. (ANDS) in effort to block the proposed takeover of Anadys Pharmaceuticals by Roche.
Those who currently are investors in shares of the Anadys Pharmaceuticals, Inc. (ANDS) and purchased ANDS shares before October 17, 2011, should contact the Shareholders Foundation, Inc. by e-mail at or call +1 (858) 779-1554.
On Oct. 17, 2011, Anadys Pharmaceuticals, Inc. (ANDS) announced that it has entered into a merger agreement to be acquired by Roche. Under the terms of the proposed transaction, Roche will commence an all cash tender offer for all outstanding shares of common stock of Anadys Pharmaceuticals, Inc. at USD 3.70 per share.
However, the plaintiff alleges that defendants breached their fiduciary duties arising out of the attempt to sell Anadys Pharmaceuticals too cheaply to Roche. Among other things, the plaintiff claims that the $3.70 offer undervalues Anadys Pharmaceuticals. Indeed, at least one analyst has set the high target price for ANDS shares at $4 per share.
Those who currently are investors in shares of the Anadys Pharmaceuticals, Inc. (ANDS) and purchased their shares before the announcement should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Trevor Allen
+1 (858) 779-1554
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.10.2011 - 07:38 Uhr
Sprache: Deutsch
News-ID 1049006
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN DIEGO, CA
Phone:
Kategorie:
Investment Services & Trading
Anmerkungen:
Diese Pressemitteilung wurde bisher 66 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Anadys Pharmaceuticals, Inc. Investor Lawsuit Against Takeover by Roche Announced by Shareholders Foundation
"
steht unter der journalistisch-redaktionellen Verantwortung von
Shareholders Foundation, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
